Dr. Day currently serves as the National Director, Head and Neck Oncology for Sarah Cannon Cancer Institute and provides multidisciplinary head and neck cancer clinical and surgical care at Head and Neck Specialists of South Carolina. He received his medical degree from the University of Oklahoma and completed his residency at Louisiana State University before pursuing a fellowship in head and neck oncologic surgery at the University of California, Davis and in craniomaxillofacial surgery at Inselspital-Bern in Bern, Switzerland. Following fellowship, he joined the faculty in the Department of Otolaryngology-Head and Neck Surgery and Department of Neurosurgery at Vanderbilt University Medical Center in Nashville, Tennessee and was later was named Professor, Vice Chair and Director of the Division of Head and Neck Oncologic Surgery in the Department of Otolaryngology-Head and Neck Surgery at the Medical University of South Carolina in Charleston, South Carolina, USA. He also served as Director of the Head and Neck Tumor Center at Hollings Cancer Center and maintained a joint appointment in the Department of Craniofacial Biology, Department of Stomatology and College of Graduate Studies.
Dr. Day currently serves on the American Joint Committee on Cancer Education Committee and is Past President of the American Head and Neck Society and served on the Council of the International Academy of Oral Oncology while having completed a four-year term on the Board of Directors of the American Academy of Otolaryngology-Head and Neck Surgery. He has served as a Senior Examiner with the American Board of Otolaryngology and has also served on the National Cancer Institute’s Head and Neck Steering Committee, Head and Neck Surgical Subcommittee for RTOG and Head and Neck Working Group for the American College of Surgeons Oncology Group. He was the first chairman of the Council of the South Carolina Cancer Alliance. Dr. Day volunteers his time as Chairman of the Board for the Head and Neck Cancer Alliance, Inc. and in 1998 started the inaugural international Oral and Head and Neck Cancer Awareness Week (OHANCAW) which now spans over 20 years of education and advocacy.
He has been active in both clinical and transitional research as a principal investigator and as co-investigator in over 25 clinical trials. He has been the recipient of numerous research grants and public health related advocacy funding for head and neck cancer. He has edited four textbooks and authored over 200 publications.
Dr. Day has limited his clinical practice to patients with tumors of the head and neck region, including robotic surgery, oropharyngeal, skin, and thyroid cancer and salivary gland tumors. He also is active in research in molecular diagnostics and therapeutics in head and neck cancer.